The availability of high-sensitivity cardiac Troponin T(hs-cTnT) allowing for early diagnosis of myocardial infarction (MI) makes it increasingly difficult for potential or novel biomarkers to compete with those utilized in current practice [7]. Here, TNNT2 is linked to myocardial infarction.